NCT06203314View on ClinicalTrials.gov

Epstein-Barr Virus and Cancer Risks

RecruitingOBSERVATIONAL
Enrollment

100,000

Participants

Timeline

Start Date

August 1, 2008

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2030

Conditions
Cancer
Interventions
OTHER

Diagnostic test: EBV antibody tests

Participants underwent several EBV antibody tests, including VCA-IgA, EBNA1-IgA, etc.

Trial Locations (2)

528403

RECRUITING

Zhongshan People's Hospital, Zhongshan

543002

RECRUITING

Wuzhou Red Cross Hospital, Wuzhou

All Listed Sponsors
collaborator

Wuzhou Red Cross Hospital

OTHER

collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

lead

Sun Yat-sen University

OTHER